Activist Investor Elliott Urges Alexion To Consider A Sale
Activist investment firm Elliott Management on Tuesday pushed Alexion Pharmaceuticals to consider a sale for the second time in less than half a year, saying company leadership has failed to show...To view the full article, register now.
Already a subscriber? Click here to view full article